Research work · 2012

Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Download PDF

DOI: 10.1016/j.jval.2012.05.006